HomeHealth CareCosette Pharmaceuticals appoints new VP Generics Commercial Operation

Cosette Pharmaceuticals appoints new VP Generics Commercial Operation

Bridgewater-based Cosette Pharmaceuticals, on Monday announced it appointed Brad Leonard as vice president, Generics Commercial Operations. In this role, Leonard will spearhead Cosette’s generics business, including Generics Sales, Marketing/Pricing, Customer Service, and Demand Planning, as the company continues its expansion in these markets.

“Cosette is in the midst of an exciting period of accelerated growth and portfolio expansion, and Brad is the right commercial leader to take our business to the next level,” Apurva Saraf, president and CEO, Cosette Pharmaceuticals, said. “Brad’s deep expertise in the pharmaceutical industry, combined with his track record of driving commercial success and fostering strategic partnerships, will be a catalyst for our continued momentum.”

Leonard played a pivotal role in the growth and success of Upsher-Smith Laboratories, LLC using a customer-focused approach to enhance their financial performance and commercial presence.

“I am honored to join Cosette at this pivotal moment in its journey,” Leonard said. “The company’s bold vision, entrepreneurial spirit, and relentless focus on innovation make this an incredibly exciting time to be part of the team. I look forward to collaborating with the talented individuals at Cosette to accelerate our commercial execution, expand our market reach, and set new standards of excellence for the customers and patients we serve.”

With 30+ years of experience in the pharmaceutical industry, Leonard is an experienced pharmaceutical executive with a robust background in pharmaceutical access and patient delivery across both generic and branded markets, cultivating and sustaining strong customer relationships, developing award-winning commercialization teams, and consistently driving sales and profit growth.

Related Articles

Robust life sciences sector stokes N.J. economy: Colliers report

The life sciences sector is growing steadily in New Jersey, according to the latest life sciences market report from Colliers. New Jersey is home...

LinusBio’s ClearStrand-ASD expands autism test range in children to 10 years

North Brunswick-based LinusBio, a leader in exposomic sequencing and precision health, announced that ClearStrand-ASD, its first-of-its-kind biochemical test designed to help rule out autism...

Merwick Post Acute in Plainsboro debuts orthopedic recovery program 

Merwick Post Acute has introduced OrthoWIN, a highly specialized subacute care program for orthopedic recovery. Dr. Stacey Miller-Smith, a physical medicine and rehabilitation (PM&R) specialist,...

Rowan University, Holy Name agree to partner on nursing education

Rowan University and Holy Name’s Sister Claire Tynan School of Nursing on March 16 announced a dual enrollment partnership for students pursuing nursing education. The...

RWJBarnabas Health appoints Giantomasi to board, honors late Chair Berson

RWJBarnabas Health has appointed Francis J. Giantomasi, Esq., as a new member of its board of trustees, effective immediately, while also posthumously honoring late...

Finding the Right Pediatrician for Your Baby and Your Family

Choosing a pediatrician is one of the earliest and most important decisions you make as a parent. Many parents research online, read reviews, and...

Latest Articles

C5i to acquire U.K.-based Datavid, strengthening agentic AI solutions

AI and analytics company C5i, headquartered in Edison, announced that it is acquiring Datavid, a data and AI company that helps organizations transform fragmented,...

GZA appoints Edward Huss associate principal, VP to bolster N.J. remediation practice

GZA GeoEnvironmental has named environmental remediation leader Edward J. “Ed” Huss an associate principal and vice president in its Fairfield office, a move the...

Farias named executive director and CEO of NJ Redevelopment Authority, succeeding Anderson

The New Jersey Redevelopment Authority (NJRA) board voted on March 16 to appoint Rose Farias as NJRA executive director and chief executive officer, effective...

Capacity appoints Sharma to chief information officer

North Brunswick-based Capacity LLC, a leading fulfillment and logistics provider for high-growth consumer brands, announced that Shatabdi Sharma has joined the company as chief...

Robust life sciences sector stokes N.J. economy: Colliers report

The life sciences sector is growing steadily in New Jersey, according to the latest life sciences market report from Colliers. New Jersey is home...

LinusBio’s ClearStrand-ASD expands autism test range in children to 10 years

North Brunswick-based LinusBio, a leader in exposomic sequencing and precision health, announced that ClearStrand-ASD, its first-of-its-kind biochemical test designed to help rule out autism...

Latest Articles

C5i to acquire U.K.-based Datavid, strengthening agentic AI solutions

AI and analytics company C5i, headquartered in Edison, announced that it is acquiring Datavid, a data and AI company that helps organizations transform fragmented,...

GZA appoints Edward Huss associate principal, VP to bolster N.J. remediation practice

GZA GeoEnvironmental has named environmental remediation leader Edward J. “Ed” Huss an associate principal and vice president in its Fairfield office, a move the...

Farias named executive director and CEO of NJ Redevelopment Authority, succeeding Anderson

The New Jersey Redevelopment Authority (NJRA) board voted on March 16 to appoint Rose Farias as NJRA executive director and chief executive officer, effective...

Capacity appoints Sharma to chief information officer

North Brunswick-based Capacity LLC, a leading fulfillment and logistics provider for high-growth consumer brands, announced that Shatabdi Sharma has joined the company as chief...

Robust life sciences sector stokes N.J. economy: Colliers report

The life sciences sector is growing steadily in New Jersey, according to the latest life sciences market report from Colliers. New Jersey is home...